BioArctic has published the company’s Interim Report for the period January – September 2019 on Thursday, October 24, 2019 at 08:00 a.m. CET.
Halting the disease progression would lead to great benefits to patients, families and caregivers.
The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.
We are developing an innovative treatment that aims to improve the patients’ quality of life.
